Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow Reinvestment Rate
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥125.07 Million (capex CN¥125.07 Million ) from operating cash flow of CN¥318.80 Million. Explore 600161 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Tiantan Biological Products Corp Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Also explore 600161 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Beijing Tiantan Biological Products Corp Ltd. For live market cap and broader valuation context, see market value of Beijing Tiantan Biological Products Corp.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.36x | CN¥1.11 Billion | CN¥819.78 Million | CN¥1.07 Billion | ▲ +29.8% |
| 2023 | 1.05x | CN¥2.51 Billion | CN¥2.39 Billion | CN¥1.08 Billion | ▼ -63.4% |
| 2022 | 2.86x | CN¥3.22 Billion | CN¥1.13 Billion | CN¥1.35 Billion | ▲ +29.9% |
| 2021 | 2.21x | CN¥2.16 Billion | CN¥980.35 Million | CN¥1.13 Billion | ▲ +149.7% |
| 2020 | 0.88x | CN¥619.92 Million | CN¥702.11 Million | CN¥608.91 Million | ▲ +2.9% |
| 2019 | 0.86x | CN¥551.23 Million | CN¥642.47 Million | CN¥526.23 Million | ▲ +79.6% |
| 2018 | 0.48x | CN¥323.90 Million | CN¥677.92 Million | CN¥293.90 Million | ▼ -39.6% |
| 2017 | 0.79x | CN¥172.87 Million | CN¥218.39 Million | CN¥144.87 Million | ▲ +42.8% |
| 2016 | 0.55x | CN¥237.39 Million | CN¥428.37 Million | CN¥209.39 Million | ▼ -20.2% |
| 2015 | 0.69x | CN¥328.57 Million | CN¥473.26 Million | CN¥300.57 Million | ▼ -28.5% |
| 2014 | 0.97x | CN¥464.16 Million | CN¥477.95 Million | CN¥464.16 Million | ▲ +0.3% |
| 2013 | 0.97x | CN¥548.37 Million | CN¥566.43 Million | CN¥548.37 Million | ▼ -25.0% |
| 2012 | 1.29x | CN¥557.87 Million | CN¥432.00 Million | CN¥557.87 Million | ▼ -36.5% |
| 2011 | 2.04x | CN¥718.67 Million | CN¥353.15 Million | CN¥718.67 Million | ▲ +26.4% |
| 2010 | 1.61x | CN¥297.54 Million | CN¥184.85 Million | CN¥297.54 Million | ▲ +277.4% |
| 2009 | 0.43x | CN¥191.17 Million | CN¥448.23 Million | CN¥191.17 Million | ▼ -21.6% |
| 2008 | 0.54x | CN¥150.31 Million | CN¥276.39 Million | CN¥150.31 Million | ▲ +25.8% |
| 2007 | 0.43x | CN¥66.40 Million | CN¥153.55 Million | CN¥66.40 Million | ▼ -6.6% |
| 2006 | 0.46x | CN¥71.50 Million | CN¥154.36 Million | CN¥71.50 Million | ▲ +53.3% |
| 2005 | 0.30x | CN¥39.78 Million | CN¥131.69 Million | CN¥39.78 Million | ▼ -61.3% |
| 2004 | 0.78x | CN¥85.89 Million | CN¥110.11 Million | CN¥85.89 Million | ▼ -45.5% |
| 2003 | 1.43x | CN¥90.02 Million | CN¥62.93 Million | CN¥90.02 Million | ▲ +246.6% |
| 2002 | 0.41x | CN¥34.83 Million | CN¥84.38 Million | CN¥34.83 Million | ▼ -60.9% |
| 2001 | 1.06x | CN¥49.09 Million | CN¥46.49 Million | CN¥49.09 Million | ▲ +14.9% |
| 2000 | 0.92x | CN¥44.04 Million | CN¥47.90 Million | CN¥44.04 Million | ▼ -9.7% |
| 1999 | 1.02x | CN¥43.34 Million | CN¥42.58 Million | CN¥43.34 Million | ▼ -58.1% |
| 1998 | 2.43x | CN¥57.61 Million | CN¥23.71 Million | CN¥57.61 Million | — |